Alexion ($23 billion, -3% YTD) is a pharma company best known for Soliris, a drug used to treat atypical hemolytic uremic syndrome and paroxysmal nocturnal hemoglobinuria  two rare disorders. Alexion ($23 billion, -3% YTD) is a pharma company best known for Soliris, a drug used to treat atypical hemolytic uremic syndrome and paroxysmal nocturnal hemoglobinuria  two rare disorders. You can find many such discontinuous pairs here. You can find many such discontinuous pairs here. The companys primary drug is its spinal muscular atrophy drug Spinraza which is licensed to Biogen BIIB .
Alexion ($23 billions, -3% YTD) is a pharma company that treats Paraly spies.
( z0 company :name ( z1 name :op "Alexion" ) :ARG0-of ( z2 treat :ARG2 ( z3 person :ARG0-of ( z4 spy :mod ( z5 disability ) ) ) ) :domain ( z6 product-of :op ( z7 percentage-entity :value 3 ) :op ( z8 percentage-entity :domain ( z9 company :quant z6 :mod z6 ) ) ) :mod ( z10 pharma ) :rel ( z11 monetary-quantity :quant 23000000 :unit ( z12 dollar ) ) :rel ( z13 year ) )
(z0 / company
    :name (z1 / name
              :op1 "Alexion")
    :ARG0-of (z2 / treat-03
                 :ARG2 (z3 / person
                           :ARG0-of (z4 / spy-01
                                        :mod (z5 / disability))))
    :domain (z6 / product-of
                :op1 (z7 / percentage-entity
                         :value 3)
                :op2 (z8 / percentage-entity
                         :domain (z9 / company
                                     :quant z6
                                     :mod z6)))
    :mod (z10 / pharma)
    :rel (z11 / monetary-quantity
              :quant 23000000
              :unit (z12 / dollar))
    :rel (z13 / year))
Alexion ( $23 billions , - 3 % YTD ) is a pharma company that treats Paraly spies .
z11 :unit z12
z11 :quant 0
z7 :value 1
z6 :op1 z7
z6 :op2 z8
z0 :mod z10
z0 :domain z6
z0 :name z1
z1 :op1 2
z8 :domain z9
z9 :mod z6
z9 :quant z6
z0 :ARG0-of z2
z2 :ARG2 z3
z3 :ARG0-of z4
z4 :mod z5
z0 :rel z11
z0 :rel z13